Configo Health is a technology company.
Configo Health has raised $2.0M across 1 funding round.
Configo Health has raised $2.0M in total across 1 funding round.
Configo Health has raised $2.0M in total across 1 funding round.
Configo Health's investors include Hatteras Venture Partners, Marc Benioff.
Configo Health is a technology company specializing in healthcare data analytics exclusively for pediatric hospitals. It builds analytical tools and services designed to help children’s hospitals and their clinical and administrative teams make better decisions through timely, trusted, and actionable insights. Its flagship product, the Opus benchmarking platform, serves leadership in Quality & Safety and Diversity, Equity & Inclusion, with plans to expand into surgical analytics. Configo addresses the unique needs of pediatric care by leveraging existing electronic medical record (EMR) data, reducing latency in reporting, and improving data quality through AI, enabling hospitals to deliver higher quality and more efficient care[1][2][3].
Founded in 2019, Configo Health emerged to fill a critical gap: pediatric hospitals lacked tailored data tools and were often forced to use adult-focused systems that did not reflect pediatric realities. The company was formed in partnership with children’s hospitals, notably with early support and investment from Children’s National Hospital and key figures such as Dr. Kurt Newman, Dr. David Wessel, and Dr. Rahul Shah. Craig Manson, the CEO, brings extensive global healthcare analytics experience, having worked across multiple countries and advised governments on risk-adjusted data use. This background shaped Configo’s mission to use data to inform and inspire better pediatric care[5].
Configo rides the growing trend of specialized healthcare analytics, focusing on pediatric care—a historically underserved segment in health IT. The timing is critical as children’s hospitals increasingly seek data-driven solutions to improve outcomes, operational efficiency, and equity in care. Market forces such as rising demand for quality benchmarking, regulatory pressures, and the expansion of AI in healthcare analytics favor Configo’s growth. By providing pediatric-specific benchmarks and reducing reliance on adult-centric tools, Configo influences the broader ecosystem by setting new standards for pediatric data use and hospital decision-making[3][4].
Configo Health is positioned for significant growth, with a forecasted 300% expansion in 2022 and recent $2 million funding led by the Pisgah Fund, signaling strong investor confidence. Future developments include launching new modules like the Surgery proposition and expanding its Health Equity analytics. Trends shaping its journey include increasing emphasis on health equity, AI-driven analytics, and the digitization of pediatric care data. As Configo scales, it is likely to deepen its influence by enabling more pediatric hospitals to leverage data for improved care quality and operational excellence, reinforcing its role as a pediatric analytics pioneer[4][3].
Configo Health has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $2.0M Seed | Hatteras Venture Partners, Marc Benioff |